Skip to content

SYNAPSE NEUROPSYCHIATRIE

Active Private limited company (pre-2019)founded 2001active for 25 yearsAvenue Gevaert 31, 1332 RixensartKBO/BCE: BE 0473.767.992

Lifetime

16 annual accounts with figures on one time axis, 19 filings since 2001
peak of €261,833 in 2024
€232,630▼ 11.2%
lowest -€39,679 in 2017
€138,617▼ 13.5%
peak of €683,013 in 2016
€614,357▲ 14.0%
€114,163▲ 131%
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Turnover from €285,393 to €238,203Dividend €63,000Equity from €538,740 to €614,357Debts from €49,348 to €114,163Cash from €13,234 to €20,087

Key points

from the 2025 annual accounts

Equity

€614,357 ▲ 14.0%
538,7402024+138,617Profit-63,000Dividend614,3572025

SYNAPSE NEUROPSYCHIATRIE paid out €63,000 in dividends. That is 45% of the 2025 profit.

Payment terms

4 days to suppliers
Suppliers
5 to 4
Customers
22 to 3

SYNAPSE NEUROPSYCHIATRIE pays its suppliers 1 day earlier than in 2024. Customers pay 19 days earlier.

Filings

19 annual accounts 61 days
AprilJune31 JulyOctober20102020

Latest accounts filed late: after the legal deadline.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as SYNAPSE NEUROPSYCHIATRIE has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,148 companies, not a prediction for SYNAPSE NEUROPSYCHIATRIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

  • deed of 17-01-2014
Board & ownership

Recent changes

Capital decrease of €540,000 to €19,000 The capital fell from €559,000 to €19,000 · General meeting of 31-10-2018 · Gazette deed
Capital increase of €540,000 to €559,000 The capital rose from €19,000 to €559,000, with 5,400 new shares · Contribution by · General meeting of 24-12-2013 · Gazette deed
Purpose change General meeting of 24-09-2008 · Gazette deed
Incorporation published on 20-01-2001 · Gazette deed
All 32 events

Official details

Source: KBO
Status
Active since 10-01-2001Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unit
Establishment unit
2.370.351.9801332 Rixensart, since 28-12-2000
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€728,520▲ 23.9%
Filing
Filed on 30-09-2026
Financials

Insights on SYNAPSE NEUROPSYCHIATRIE

SYNAPSE NEUROPSYCHIATRIE files the micro format. The filing also states the turnover: €238,203 in 2025. The gross margin rose from €126,461 in 2003 to €232,630 in 2025.

The balance sheet grew most in 2009 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SYNAPSE NEUROPSYCHIATRIE

What is the company number of SYNAPSE NEUROPSYCHIATRIE?
The company number of SYNAPSE NEUROPSYCHIATRIE is 0473.767.992. The VAT number is the same number with BE in front: BE 0473.767.992.
Where is SYNAPSE NEUROPSYCHIATRIE based?
The registered office is at Avenue Gevaert 31, 1332 Rixensart.Company details
What does SYNAPSE NEUROPSYCHIATRIE do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of SYNAPSE NEUROPSYCHIATRIE?
SYNAPSE NEUROPSYCHIATRIE is a private limited company (pre-2019) (BVBA).
When was SYNAPSE NEUROPSYCHIATRIE founded?
SYNAPSE NEUROPSYCHIATRIE was founded on 10-01-2001.
Is SYNAPSE NEUROPSYCHIATRIE still active?
Yes, SYNAPSE NEUROPSYCHIATRIE is an active enterprise in the KBO register.
What is the turnover of SYNAPSE NEUROPSYCHIATRIE?
The turnover of SYNAPSE NEUROPSYCHIATRIE was €238,203 in financial year 2025, according to the filed annual accounts.Financials
Is SYNAPSE NEUROPSYCHIATRIE profitable?
In financial year 2025, SYNAPSE NEUROPSYCHIATRIE made a profit of €138,617.
Where can I find the annual accounts of SYNAPSE NEUROPSYCHIATRIE?
SYNAPSE NEUROPSYCHIATRIE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SYNAPSE NEUROPSYCHIATRIE due?
SYNAPSE NEUROPSYCHIATRIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.